Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Non Operating Income: 2023-2025

Historic Non Operating Income for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to $1.1 million.

  • Zenas BioPharma's Non Operating Income fell 54.54% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 100.02%. This contributed to the annual value of $8.2 million for FY2024, which is 1210.10% up from last year.
  • Zenas BioPharma's Non Operating Income amounted to $1.1 million in Q3 2025, which was down 63.48% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Non Operating Income ranged from a high of $3.6 million in Q1 2025 and a low of -$16,000 during Q3 2023.
  • In the last 3 years, Zenas BioPharma's Non Operating Income had a median value of $1.9 million in 2024 and averaged $1.8 million.
  • In the last 5 years, Zenas BioPharma's Non Operating Income soared by 14,962.50% in 2024 and then plummeted by 54.54% in 2025.
  • Quarterly analysis of 3 years shows Zenas BioPharma's Non Operating Income stood at $793,000 in 2023, then spiked by 334.80% to $3.4 million in 2024, then crashed by 54.54% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $3.0 million for Q2 2025, and $3.6 million during Q1 2025.